GURU.Markets stock price, segment price, and overall market index valuation
The company's share price 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases. Its stock price reflects the commercial success of its drugs. This chart tells the story of a company working in an important, yet often underfunded, area of medicine.
Share prices of companies in the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs to treat infectious diseases such as malaria. We've categorized it as "Pharma: Infections." The chart below shows how investors value companies in this important field.
Broad Market Index - GURU.Markets
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development of drugs to treat infectious diseases, particularly malaria. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
SXTP - Daily change in the company's share price 60 Degrees Pharmaceuticals
The daily price change of 60 Degrees Pharmaceuticals, Inc. reflects the high volatility inherent in pharmaceutical companies. This indicator measures the sensitivity to news about the company's sales and development of infectious disease drugs.
Daily change in the price of a set of shares in a market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment of infectious diseases, including malaria. This pharmaceutical niche is volatile and dependent on grants and approvals. The chart below shows the average fluctuations in the sector, which helps assess the risks and dynamics of SXTP.
Daily change in the price of a broad market stock, index - GURU.Markets
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in infectious diseases. Its shares are driven by news about new drug developments. This dynamic, specific to the pharmaceutical industry, creates fluctuations that contribute to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals' year-to-date performance is a story of the commercialization of its infectious disease drugs. Its 12-month market cap growth reflects its success in bringing FDA-approved malaria prevention drugs to market. Its valuation is a bet on its niche products finding a market.
Annual dynamics of market capitalization of the market segment - Pharma infections
60 Degrees, as a pharmaceutical company, specializes in treating infectious diseases. Its performance relative to the sector will demonstrate the success of its commercial strategy for niche but important drugs and how it is impacted by government procurement and disease outbreaks.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
60 Degrees Pharmaceuticals, a pharmaceutical company specializing in the treatment and prevention of infectious diseases such as malaria, operates in a market critical to developing countries and travelers. Its year-over-year market capitalization reflects both the commercial potential and humanitarian impact of its products.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a commercial pharmaceutical company specializing in travel medications. Its monthly sales are driven by sales of its anti-malaria drugs, which in turn are driven by the recovery of international tourism.
Monthly dynamics of market capitalization of the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. This is a niche market. The company's success depends on demand from travelers and the military, as well as government programs. The pharmaceutical sector chart provides only a general overview of this specific business model.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
60 Degrees Pharmaceuticals develops drugs to treat infectious diseases, particularly malaria. This is a highly specialized area. The company's stock price is not driven by the market, but is driven by contract news (for example, with the military) and progress in developing drugs for travelers and tropical regions.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals, a company developing drugs to treat infectious diseases, including malaria, operates in a market with high social impact. Its weekly stock price reflects news of clinical trials and contracts from government and military organizations.
Weekly dynamics of market capitalization of the market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs to treat infectious diseases, including malaria. Demand for its products may be driven by geographic and epidemiological factors. The chart helps assess its performance relative to the pharmaceutical sector as a whole.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
60 Degrees Pharmaceuticals specializes in drugs for infectious diseases, including malaria. Its business is unique and less dependent on general economic cycles. The chart will help you assess how stable its shares are compared to the volatile market.
Market capitalization of the company, segment and market as a whole
SXTP - Market capitalization of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals' market capitalization reflects investors' assessment of its focus on treating and preventing infectious diseases. The chart shows how the market values its drugs, particularly those for malaria. Its small scale reflects its niche position in the travel and military-focused market.
SXTP - Share of the company's market capitalization 60 Degrees Pharmaceuticals within the market segment - Pharma infections
60 Degrees Pharmaceuticals is a company specializing in the development and commercialization of drugs for the treatment of infectious diseases. Its market share in the pharmaceutical sector is small, but it targets niche markets, such as malaria prevention, where it offers novel solutions.
Market capitalization of the market segment - Pharma infections
This chart shows the total market capitalization of the entire pharmaceutical sector focused on infectious diseases. For 60 Degrees, which specializes in tropical disease drugs, this line is a map of global health. Its dynamics reflect the world's willingness to invest in fighting diseases often overlooked by large pharmaceutical companies.
Market capitalization of all companies included in a broad market index - GURU.Markets
60 Degrees Pharmaceuticals develops drugs for the treatment and prevention of infectious diseases, particularly malaria. Its market capitalization reflects its focus on tropical medicine. Its market share is determined by its focus on treating diseases common in developing countries.
Book value capitalization of the company, segment and market as a whole
SXTP - Book value capitalization of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals develops drugs to treat and prevent infectious diseases. Its book value represents its financial resources and development pipeline. This represents its capital for commercialization and new research. How has it changed? The chart below shows this history.
SXTP - Share of the company's book capitalization 60 Degrees Pharmaceuticals within the market segment - Pharma infections
60 Degrees Pharmaceuticals develops drugs to treat infectious diseases. Its operations require a resource base: laboratories for research and manufacturing facilities for product release. The chart shows the company's share of the R&D and operational infrastructure required for this pharmaceutical segment.
Market segment balance sheet capitalization - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company. Pharmaceuticals, as the graph shows, are knowledge- and capital-intensive. As a commercial company, 60 Degrees invests not only in R&D but also in the infrastructure to market its products.
Book value of all companies included in the broad market index - GURU.Markets
60 Degrees Pharmaceuticals' assets are not manufacturing plants, but primarily commercial infrastructure for promoting an FDA-approved malaria prevention drug. The book value reflects the capital invested in bringing this important, yet niche, product to the US market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases. Its market capitalization is based on its product portfolio, including malaria prophylaxis, and its ability to capture niche markets.
Market to book capitalization ratio in a market segment - Pharma infections
60 Degrees Pharmaceuticals is a company developing drugs to treat infectious diseases. The chart shows how investors view its portfolio and its ability to bring new drugs to market in this important, yet often underfunded, area of medicine.
Market to book capitalization ratio for the market as a whole
60 Degrees Pharmaceuticals develops drugs to treat infectious diseases, particularly malaria. The company's market value reflects both its approved products and the potential for new developments. This metric provides an insight into how investors view pharmaceutical companies operating in emerging markets.
Debts of the company, segment and market as a whole
SXTP - Company debts 60 Degrees Pharmaceuticals
60 Degrees, a pharmaceutical company specializing in infectious diseases, uses capital to commercialize its approved products and for R&D. This chart shows the financial needs of a small pharmaceutical company as it ramps up sales and promotes its niche drugs.
Market segment debts - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs to treat infectious diseases, particularly malaria. This chart illustrates how the company, operating in a niche and often underfunded field of medicine, manages its capital to bring life-saving drugs to market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs to treat infectious diseases, particularly malaria. Obtaining approval and bringing even niche drugs to market requires significant capital. This chart shows how the company uses debt to finance its activities in the specific field of tropical medicine.
Market segment debt to market segment book capitalization - Pharma infections
60 Degrees Pharmaceuticals is a small pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. This chart shows how the company finances its operations, comparing its debt load to the market capitalization of the entire pharmaceutical sector.
Debt to book value of all companies in the market
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment of tropical infectious diseases. This is an important yet often overlooked area of pharmaceuticals. How reliant is the company on debt? This chart of total debt in the economy helps evaluate its financial strategy in this niche.
P/E of the company, segment and market as a whole
P/E - 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. This chart shows how investors value it in the niche tropical medicine market.
P/E of the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly malaria. This chart illustrates the average valuation in the pharmaceutical sector, where demand for travel and military medications, as well as government procurement, is important.
P/E of the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly malaria. This chart reflects the overall sentiment in the pharmaceutical sector. It helps understand what influences SXTP's valuation more: general market trends or specific demand for its products, including from the military.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly those relevant to travelers and the military. This chart reflects investor expectations regarding future demand for these drugs and the company's success in bringing its products to market.
%20P%2FE%2060%20Degrees%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-60-Degrees-Pharmaceuticals&v=1772655371948 "Chart of the company's future (projected) P/E 60 Degrees Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. The chart reflects future revenue forecasts for the sector. It helps understand how the market views the commercial prospects of drugs for diseases prevalent primarily in emerging markets.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-infections&v=1772655371977 "Future (projected) P/E graph of the market segment - Pharma infections")
Future (projected) P/E of the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs to treat infectious diseases, particularly malaria. This overall risk appetite chart helps assess investor sentiment toward companies operating in markets with significant humanitarian, but not always commercial, needs.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772655372036 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly malaria. Profits are driven by sales of its drugs. This chart shows financial results in the niche but critically important field of tropical medicine.
Profit of companies in the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly those prevalent in the tropics. This chart shows overall profitability in the infectious disease pharmaceutical sector, where global travel and climate change pose new challenges.
Overall market profit
60 Degrees Pharmaceuticals develops medications for the treatment and prevention of infectious diseases, particularly malaria. Demand for these medications is driven by the needs of travelers and residents of endemic regions, not by the state of the global economy. The company's success depends on the effectiveness of its drugs, not on the cycles visible in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. Future profits depend on sales of its products, particularly to travelers and the military. This chart shows analysts' expectations for demand for drugs to prevent tropical diseases.
%20profit%20of%20the%20company%2060%20Degrees%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-60-Degrees-Pharmaceuticals&v=1772655372289 "Graph of future (projected) profit of the company 60 Degrees Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly those prevalent in tropical regions. This chart shows profitability expectations for the pharmaceutical sector, providing context for assessing the company's niche strategy in global healthcare.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-infections&v=1772655372314 "Graph of future (predicted) profits of companies in a market segment - Pharma infections")
Future (predicted) profit of the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development of drugs to treat infectious diseases. Its commercial success depends on regulatory approval and demand for its products. This economic outlook influences government healthcare spending and preparedness to combat tropical diseases.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772655372421 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals develops drugs for the treatment and prevention of infectious diseases, particularly malaria. Revenue depends on sales of its approved products. This chart shows how investors assess its market niche and the demand for medications for travelers and residents of endemic regions.
P/S market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the prevention and treatment of infectious diseases, with a particular focus on malaria. This chart reflects the average revenue estimate for the sector, providing insight into how the market values the company's niche, yet important, products for global healthcare.
P/S of the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. This chart helps understand how the market values companies working on global health issues that may have a significant social impact but a limited commercial market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. Estimating future revenue is important to the company. It reflects how investors view the demand for its drugs among travelers and the military, as well as its potential for expansion into other tropical diseases.
%20P%2FS%2060%20Degrees%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-60-Degrees-Pharmaceuticals&v=1772655372613 "The graph of the company's future (projected) P/S 60 Degrees Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases. This chart compares the company's estimated future sales with industry expectations. It shows how investors view its portfolio of drugs aimed at preventing and treating tropical and other infections.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20infections&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-infections&v=1772655372742 "Future (projected) P/S market segment graph - Pharma infections")
Future (projected) P/S of the market as a whole
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs for the treatment and prevention of infectious diseases, including malaria. The company's success depends on demand for its niche products. This graph of investor expectations reflects their view of the pharmaceutical market and the importance of combating infectious diseases, particularly in tropical regions.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772655372820 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales 60 Degrees Pharmaceuticals
For 60 Degrees Pharmaceuticals, this figure reflects revenue from sales of its drugs developed for the prevention and treatment of infectious diseases such as malaria. Revenue growth is driven by demand from travelers, the military, and residents of endemic regions.
Sales of companies in the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases. Its revenue is generated by sales of a malaria prophylaxis drug. The sales breakdown shows which markets (military, travel) are most in demand for its product.
Overall market sales
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs to treat infectious diseases, particularly those prevalent in tropical regions. This general economics chart is irrelevant to the company, whose mission is to combat diseases that affect millions of people but are often ignored by large pharmaceutical companies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, primarily malaria. Revenue growth depends on sales of its approved drugs. This chart shows analysts' expectations for demand for its products from travelers and the military.
%20sales%20of%20the%20company%2060%20Degrees%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-60-Degrees-Pharmaceuticals&v=1772655373075 "Schedule of future (projected) sales of the company 60 Degrees Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs to treat infectious diseases. This chart shows the outlook for the pharmaceutical market. Is the need for new drugs to prevent and treat tropical diseases and other infections growing? This reflects general expectations.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-infections&v=1772655373108 "Schedule of future (projected) sales of companies in the market segment - Pharma infections")
Future (projected) sales of the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases, particularly malaria. Demand for its products is driven by the needs of travelers and residents in endemic regions, as well as government healthcare programs. This overall economic activity schedule is of secondary importance to the company.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772655373145 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly malaria. This chart shows its financial trajectory. Profitability depends on sales of its approved drugs and demand from travelers and military personnel seeking protection against tropical diseases.
Market segment marginality - Pharma infections
60 Degrees Pharmaceuticals, Inc. is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. This metric reflects its financial performance, where profitability depends on sales of its products to travelers and the military, as well as government contracts.
Market marginality as a whole
60 Degrees Pharmaceuticals develops drugs for the treatment and prevention of infectious diseases, particularly malaria. The company operates at the intersection of commercial pharmaceuticals and global health. This overall profitability chart reflects the investment climate that influences funding for tropical disease drug development.
Employees in the company, segment and market as a whole
Number of employees in the company 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases, particularly malaria. Its small and flexible team manages the approval and market launch process, often focusing on the needs of travelers and the military.
Share of the company's employees 60 Degrees Pharmaceuticals within the market segment - Pharma infections
60 Degrees Pharmaceuticals specializes in the development and commercialization of drugs to treat infectious diseases, particularly malaria. The company's operations require a team of scientists, physicians, and tropical medicine specialists. This chart shows its market share, reflecting its focus on a specific and important pharmaceutical niche.
Number of employees in the market segment - Pharma infections
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment and prevention of infectious diseases, particularly those common among travelers and the military. The chart illustrates its work in this area. Its focus on niche infections allows the company to occupy a unique market.
Number of employees in the market as a whole
60 Degrees Pharmaceuticals develops drugs to treat and prevent infectious diseases, particularly malaria. Its activities are driven by global health needs, not economic cycles. This chart shows general trends, and 60 Degrees is an example of a company working to solve global health problems while creating jobs for scientists.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company 60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases (such as malaria). They have approved drugs. This chart shows how the market values their commercial products and pipeline. It reflects the market value per employee, which is a measure of the value of their niche assets.
%20of%20the%20company%2060%20Degrees%20Pharmaceuticals%20(SXTP)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-60-Degrees-Pharmaceuticals-SXTP&v=1772655373730 "Chart of market capitalization per employee (in thousands of dollars) of the company 60 Degrees Pharmaceuticals (SXTP)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma infections
60 Degrees Pharmaceuticals (SXTP) develops drugs for the prevention and treatment of infectious diseases, particularly malaria. In this area of pharmaceuticals, this indicator reflects both commercial and humanitarian potential. The high employee rating may be due to the fact that their drugs are in demand by both the military and travelers to tropical regions.
%20by%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-infections&v=1772655373784 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma infections")
Market capitalization per employee (in thousands of dollars) for the overall market
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the development and commercialization of drugs for the treatment of infectious diseases. Its value is dependent on the success of its products. This metric reflects how the market perceives the potential of its portfolio to meet the needs of travelers and military personnel working in tropical regions.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772655373835 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company 60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases, specifically malaria (they already have an approved drug). This chart shows how successfully the company is commercializing its niche drug. Earnings per employee here is the sales revenue that covers R&D and marketing.
%20Chart%2060%20Degrees%20Pharmaceuticals%20(SXTP)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-60-Degrees-Pharmaceuticals-SXTP&v=1772655373853 "Company Profit Per Employee (in thousands of dollars) Chart 60 Degrees Pharmaceuticals (SXTP)")
Profit per employee (in thousands of dollars) in the market segment - Pharma infections
60 Degrees Pharmaceuticals, Inc. specializes in the development and commercialization of drugs to treat infectious diseases, including malaria. In this important yet often underfunded area of pharmaceuticals, the efficiency of a small team is critical. The graph shows the financial return per employee, which is an indicator of their ability to bring the right drugs to market.
%20in%20the%20market%20segment%20-%20Pharma%20infections&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-infections&v=1772655373875 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma infections")
Profit per employee (in thousands of dollars) for the market as a whole
60 Degrees Pharmaceuticals is a pharmaceutical company specializing in the treatment of infectious diseases, specifically malaria (Arakoda). It's a niche pharmaceutical. This chart helps understand how a business focused on a niche hospital/military drug compares in terms of staff efficiency to the market average.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772655373898 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee 60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals develops drugs to treat infectious diseases. This schedule becomes crucial during the commercialization phase. Increasing revenue per employee will translate into successful sales of their malaria prevention drugs, for example, allowing the small team to generate significant revenue.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-60-Degrees-Pharmaceuticals-SXTP&v=1772655373941 "Sales chart per company employee 60 Degrees Pharmaceuticals (SXTP)")
Sales per employee in the market segment - Pharma infections
60 Degrees Pharmaceuticals (SXTP) is a pharmaceutical company specializing in infectious diseases, specifically, they have an approved malaria prophylaxis drug (Arakoda). This chart shows the average revenue in the sector. For SXTP, this is an indicator of how productive their small commercial team is in promoting this niche drug.
Sales per employee for the market as a whole
60 Degrees Pharmaceuticals is a commercial-stage pharmaceutical company. They specialize in treating infectious diseases, with their key product being a malaria drug. This indicator demonstrates how effective their small, focused team is in selling this niche drug.
Short shares by company, segment and market as a whole
Shares shorted by company 60 Degrees Pharmaceuticals (SXTP)
60 Degrees (SXTP) is a pharmaceutical company specializing in the treatment of infectious diseases, particularly malaria. This chart tracks short positions. Short positions may be related to the fact that the malaria drug market (primarily in developing countries) is considered low-margin and complex.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-60-Degrees-Pharmaceuticals-SXTP&v=1772655374071 "Short Shares Chart for the Company 60 Degrees Pharmaceuticals (SXTP)")
Shares shorted by market segment - Pharma infections
60 Degrees Pharmaceuticals (SXTP) is a pharmaceutical company specializing in the development and commercialization of drugs to treat infectious diseases, particularly malaria. This chart shows the total short position in the pharmaceutical sector, reflecting investor concerns about the profitability of drugs for tropical diseases.
Shares shorted by the overall market
60 Degrees Pharmaceuticals sells drugs against malaria and tropical diseases. It's a very niche market. This chart illustrates the overall market pessimism. Investors may worry that the company's focus is too narrow, and its target markets (travelers, developing countries) are vulnerable to economic downturns.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator 60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals specializes in infectious diseases, including malaria. This is an important, but often low-margin (for Western markets) area. This chart represents the approvals "pulse." It "warms" on news of contracts (for example, with the military) or FDA approvals for travelers.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-60-Degrees-Pharmaceuticals-SXTP&v=1772655374142 "RSI 14 indicator chart for the company's stock 60 Degrees Pharmaceuticals (SXTP)")
RSI 14 Market Segment - Pharma infections
60 Degrees (SXTP) is a pharmaceutical company specializing in infectious diseases, specifically, they received FDA approval for a malaria treatment. This chart tracks overall sentiment in the Pharma/Infectious Diseases sector. It helps investors understand whether SXTP's performance reflects their niche or whether the overall biotech sector is overheated or oversold.
RSI 14 for the overall market
For 60 Degrees (SXTP), a biotech company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the money supply is turned off, and companies burning through cash risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SXTP (60 Degrees Pharmaceuticals)
60 Degrees Pharmaceuticals is a company focused on infectious diseases. Its key asset is ARAKODA, an FDA-approved malaria prophylaxis drug. This chart shows the average analyst price target, which is almost entirely dependent on their sales and commercial success forecasts for the drug.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SXTP-60-Degrees-Pharmaceuticals&v=1772655374204 "A chart showing analyst consensus forecasts for the expected stock price. SXTP (60 Degrees Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price SXTP (60 Degrees Pharmaceuticals)
60 Degrees Pharma is a niche pharmaceutical company specializing in tropical diseases. Their flagship product is an FDA-approved malaria preventative. This chart shows how far the current share price differs from the "fair" value. It reflects analysts' views on this niche but critically important market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SXTP-60-Degrees-Pharmaceuticals&v=1772655374225 "A chart showing the difference between the consensus forecast and the actual stock price. SXTP (60 Degrees Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma infections
60 Degrees (SXTP) is a pharmaceutical company specializing in the treatment of tropical infectious diseases, such as malaria (the drug Arakoda). This chart shows the overall expectations of analysts for the pharmaceutical sector. It reflects whether experts believe in the commercial success of drugs for "traveler's diseases."
Analysts' consensus forecast for the overall market share price
60 Degrees Pharmaceuticals (SXTP) is a pharmaceutical company specializing in the treatment of infectious diseases, particularly malaria (the drug Arakoda). This chart reflects the overall "risk appetite" in the market. For SXTP, which operates in the "defensive" sector (infections need to be treated), overall optimism is important for funding R&D and bringing its drugs to market.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index 60 Degrees Pharmaceuticals
60 Degrees (SXTP) is a tropical pharma company. Their specialty is R&D and commercialization of drugs for tropical diseases; in particular, their only FDA-approved product is a malaria prophylaxis pill. This chart is a summary indicator of their niche model. It reflects their (meager) sales and their (difficult) path to monetizing this ultra-niche tourism market.
AKIMA Market Segment Index - Pharma infections
60 Degrees Pharmaceuticals (SXTP) is a niche pharmaceutical company focused on tropical diseases. Their flagship product is Arakoda, an FDA-approved malaria *preventative* intended for travelers and the military. This chart shows the segment's average index, helping investors assess the success of this niche strategy.
The AKIM Index for the overall market
60 Degrees Pharmaceuticals is a specialty pharmaceutical company commercializing drugs for infectious diseases (malaria - Arakoda). This chart, reflecting the market average, provides a macro backdrop. It helps assess how SXTP, a niche company in tropical medicine, compares to overall economic trends.
